CHELSEA O'MALLEY: Open Payments
NPI 1336729490 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $86 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Boston Scientific Corporation | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Wegovy, LifeVest, SAPIEN 3 Ultra RESILIA, Assure WCD, VIGILANT X4 CRT-D, JARDIANCE, CAMZYOS.
Industry payments across IL — which companies pay providers there.
